{"news_desk": "Editorial", "print_page": "24", "section_name": "Opinion", "subsection_name": null, "byline": {"original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial urges FDA to suspend sales of birth control implant Essure, in light of mounting complaints that device has harmed women; notes over 5,000 women have reported harmful effects tied to Essure; calls for independent investigation into device and says it should be discontinued until better data is available.", "type_of_material": "Editorial", "word_count": "379", "lead_paragraph": "Until there is better data, the F.D.A. should consider suspending sales of Essure, a contraceptive implant.", "pub_date": "2015-10-14T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Safety Questions About a Birth Control Device ", "content_kicker": "Editorial", "print_headline": "Safety Questions About a Birth Control Device   ", "kicker": "Editorial"}, "snippet": "Until there is better data, the F.D.A. should consider suspending sales of Essure, a contraceptive implant.", "multimedia": [{"height": 126, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/10/14/opinion/14wed3web/14wed3web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/10/14/opinion/14wed3web/14wed3web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/10/14/opinion/safety-questions-about-a-birth-control-device.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Birth Control and Family Planning", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Medical Devices", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Clinical Trials", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "American College of Obstetricians and Gynecologists", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Planned Parenthood Federation of America", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Health and Human Services Department", "name": "organizations"}, {"rank": "9", "is_major": "Y", "value": "Implants", "name": "subject"}], "blog": [], "_id": "561e026438f0d86f05abece0", "source": "The New York Times"}